Akineton Related Published Studies
Well-designed clinical trials related to Akineton (Biperiden)
Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. [2010.06]
Comparison of the efficacy and impact on cognition of glycopyrrolate and
biperiden for clozapine-induced sialorrhea in schizophrenic patients: a
randomized, double-blind, crossover study. [2010]
Modulation of memory and visuospatial processes by biperiden and rivastigmine in elderly healthy subjects. [2005.09]
Well-designed clinical trials possibly related to Akineton (Biperiden)
Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study. [2011.08]
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial. [2011.03]
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective
disorder: results of an 8-week double-blind randomized controlled trial. [2011]
A randomized, double-blind comparison of risperidone versus low-dose risperidone
plus low-dose haloperidol in treating schizophrenia. [2010]
Ziprasidone Vs Olanzapine in Recent-Onset Schizophrenia and Schizoaffective Disorder: Results of an 8-Week Double-Blind Randomized Controlled Trial. [2009.06.19]
Modification of practice-dependent plasticity in human motor cortex by neuromodulators. [2006.08]
Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial. [2005.02]
Other research related to Akineton (Biperiden)
A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. [2011.06]
Effects of discontinuation of long-term biperiden use on cognitive function and quality of life in schizophrenia. [2011.01.15]
Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions. [2008.12.03]
The effectiveness of intramuscular biperiden in acute akathisia: a double-blind, randomized, placebo-controlled study. [2007.06]
Biperiden-induced delirium model in rats: a behavioral and electroencephalographic study. [2006.10.18]
Administration of haloperidol with biperiden reduces mRNAs related to the ubiquitin-proteasome system in mice. [2005.06.15]
Other possibly related research studies
Acute dystonia with low-dosage aripiprazole in Tourette's disorder. [2006.04]
Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in rat plasma. [2006.01]
Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects. [2005.10]
Scopolamine-induced convulsions in fasted mice after food intake: effects of glucose intake, antimuscarinic activity and anticonvulsant drugs. [2005.09]
Clozapine improves working memory updating in schizophrenia. [2005.12]
Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. [2006.05]
Acute dystonia after initial doses of ziprasidone: a case report. [2006.06]
Possible malignant neuroleptic syndrome that associated with hypothyroidism. [2005.06]
Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser. [2005.01]
Acute dystonia resulting from abrupt bupropion discontinuation. [2007.04.13]
Neuroleptic malignant syndrome induced by ziprasidone on the second day of treatment. [2007]
[Therapy of postoperative nausea and vomiting in ENT--tardive dyskinesia as an adverse effect of metoclopramid--a case report] [2006.11]
[The prevalence and pharmacological cost of Parkinson's disease in Spain] [2006.12.01]
Empirical validation of competing definitions of schizophrenia: a poly-diagnostic study of cognitive impairment in non-affective psychosis. [2007.09]
The successful use of ondansetron in a boy with both leukemia and Tourette syndrome. [2008.01]
Methamphetamine psychosis in which tardive dystonia was successfully treated with clonazepam. [2007.12]
A somatic type delusional disorder secondary to peripheral neuropathy: a case report. [2008.03]
A case of respiratory akathisia in a cancer patient: a case report. [2008.03]
Anticonvulsant efficacy of drugs with cholinergic and/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman. [2008.02]
Antiparkinson drugs used as prophylactics for nerve agents: studies of cognitive side effects in rats. [2008.06]
Typical and atypical antipsychotics--the misleading dichotomy. Results from the Working Group 'Drugs in Psychiatry' (AGATE). [2008]
Serotonin syndrome caused by olanzapine and clomipramine. [2008.01]
Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study. [2008.09]
The antidepressant effects of anticholinergic drugs. [2009.06]
Effects of Plantago ovata husk on levodopa (with Carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders. [2009.07]
Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome. [2009.03]
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis. [2009.04]
The use and potential abuse of anticholinergic antiparkinson drugs in Norway: a pharmacoepidemiological study. [2009.02]
A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. [2010.10]
[Antiemetic-induced extrapyramidal symptoms seen by our palliative care team] [2010.05]
The use of antipsychotic and anticholinergic antiparkinson drugs in Norway after the withdrawal of orphenadrine. [2009.08]
Torticollis under cyclobenzaprine. [2009]
Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders. [2009.08]
Polypharmacy in the treatment of schizophrenic patients in three University Centers in the Federation of Bosnia and Herzegovina (F/BH). [2011.03]
Hemiparkinsonism-hemiatrophy syndrome. [2011.03]
Effects of the CYP2D6*10 allele on the steady-state plasma concentrations of aripiprazole and its active metabolite, dehydroaripiprazole, in Japanese patients with schizophrenia. [2011.02]
Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study. [2010.05]
Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex:
a pharmaco-TMS study. [2011]
|
